Health Trials

About this trial

This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.

Eligibility criteria

Qualifiers

Women aged 18 to 45 years

Clinically, radiologically, or laparoscopically diagnosed endometriosis

Chronic pelvic pain persisting for at least 6 months

Stable pharmacological or hormonal treatment for at least 3 months before enrollment

Disqualifiers

Pregnancy or planned pregnancy during the study period

History of gynecological or pelvic malignancy

Active pelvic inflammatory disease or acute pelvic infection

Implanted electronic medical devices such as pacemakers or neurostimulators

Trial design

Treatments tested in this trial

  • Pulsed Electromagnetic Field Therapy
  • Sham pulsed electromagnetic field therapy

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

1
Outpatient clinic, faculty of Physical Therapy, Beni Suef University Banī Suwayf Egypt

Sponsors and collaborators

Beni-Suef University

Lead sponsor

Source ClinicalTrials.gov